Phibro Animal Health Corp... (PAHC)
Phibro Animal Health Statistics
Share Statistics
Phibro Animal Health has 40.5M shares outstanding. The number of shares has increased by 0% in one year.
Shares Outstanding | 40.5M |
Shares Change (YoY) | 0% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | 51.19% |
Shares Floating | 40.2M |
Failed to Deliver (FTD) Shares | 233 |
FTD / Avg. Volume | 0.09% |
Short Selling Information
The latest short interest is 848.24K, so 2.09% of the outstanding shares have been sold short.
Short Interest | 848.24K |
Short % of Shares Out | 2.09% |
Short % of Float | 5.88% |
Short Ratio (days to cover) | 4.21 |
Valuation Ratios
The PE ratio is 285.67 and the forward PE ratio is 8.89. Phibro Animal Health's PEG ratio is -3.08.
PE Ratio | 285.67 |
Forward PE | 8.89 |
PS Ratio | 0.68 |
Forward PS | 0.5 |
PB Ratio | 2.69 |
P/FCF Ratio | 14.89 |
PEG Ratio | -3.08 |
Enterprise Valuation
Phibro Animal Health has an Enterprise Value (EV) of 1.15B.
EV / Sales | 1.13 |
EV / EBITDA | 13.53 |
EV / EBIT | 13.07 |
EV / FCF | 24.7 |
Financial Position
The company has a current ratio of 2.94, with a Debt / Equity ratio of 2.05.
Current Ratio | 2.94 |
Quick Ratio | 1.64 |
Debt / Equity | 2.05 |
Debt / EBITDA | 6.21 |
Debt / FCF | 11.34 |
Interest Coverage | 2.43 |
Financial Efficiency
Return on Equity is 0.94% and Return on Invested Capital is 1.45%.
Return on Equity | 0.94% |
Return on Assets | 0.25% |
Return on Invested Capital | 1.45% |
Revenue Per Employee | $524.58K |
Profits Per Employee | $1.25K |
Employee Count | 1,940 |
Asset Turnover | 1.04 |
Inventory Turnover | 2.65 |
Taxes
Income Tax | 8.5M |
Effective Tax Rate | 77.87% |
Stock Price Statistics
The stock price has increased by 32.29% in the last 52 weeks. The beta is 0.63, so Phibro Animal Health's price volatility has been higher than the market average.
Beta | 0.63 |
52-Week Price Change | 32.29% |
50-Day Moving Average | 21.87 |
200-Day Moving Average | 21.42 |
Relative Strength Index (RSI) | 33.83 |
Average Volume (20 Days) | 268.1K |
Income Statement
In the last 12 months, Phibro Animal Health had revenue of 1.02B and earned 2.42M in profits. Earnings per share was 0.06.
Revenue | 1.02B |
Gross Profit | 313.09M |
Operating Income | 53.31M |
Net Income | 2.42M |
EBITDA | 84.61M |
EBIT | 32.89M |
Earnings Per Share (EPS) | 0.06 |
Balance Sheet
The company has 70.61M in cash and 525.46M in debt, giving a net cash position of -454.85M.
Cash & Cash Equivalents | 70.61M |
Total Debt | 525.46M |
Net Cash | -454.85M |
Retained Earnings | 243.89M |
Total Assets | 1.29B |
Working Capital | 512.9M |
Cash Flow
In the last 12 months, operating cash flow was 87.59M and capital expenditures -41.24M, giving a free cash flow of 46.36M.
Operating Cash Flow | 87.59M |
Capital Expenditures | -41.24M |
Free Cash Flow | 46.36M |
FCF Per Share | 1.14 |
Margins
Gross margin is 30.77%, with operating and profit margins of 5.24% and 0.24%.
Gross Margin | 30.77% |
Operating Margin | 5.24% |
Pretax Margin | 1.07% |
Profit Margin | 0.24% |
EBITDA Margin | 8.31% |
EBIT Margin | 5.24% |
FCF Margin | 4.56% |
Dividends & Yields
PAHC pays an annual dividend of $0.6, which amounts to a dividend yield of 2.04%.
Dividend Per Share | $0.60 |
Dividend Yield | 2.04% |
Dividend Growth (YoY) | 0% |
Payout Ratio | 125% |
Earnings Yield | 0.35% |
FCF Yield | 6.72% |
Analyst Forecast
The average price target for PAHC is $22, which is 27.5% higher than the current price. The consensus rating is "Hold".
Price Target | $22 |
Price Target Difference | 27.5% |
Analyst Consensus | Hold |
Analyst Count | 4 |
Scores
Altman Z-Score | 2.19 |
Piotroski F-Score | 7 |